Alternative Cancer Protocol Claims

What these protocols are, what people claim is in them, and why they remain unproven.

Jump to Protocols Agent Research Library

Read this first: These protocols exist in public discussion. People talk about them in books, interviews, clinics, forums, social media groups, and caregiver circles. That does not make them proven.

Despite many claims of success, reports from people who have tried them vary wildly. Some people believe they helped. Some saw no benefit. Some had side effects or lost time. OncoForge does not claim that any protocol works to diagnose, treat, cure, mitigate, or prevent any disease.

Dosing note: Dose ranges below are based on anecdotal reports, books, clinics, social posts, or publicly discussed protocol claims. They are not OncoForge recommendations. Large-scale studies are needed to verify safety and effectiveness. Consult your oncologist, pharmacist, or qualified clinician for safe dosing information.

Quick Comparison

Protocol Claim	Main Idea	Evidence Reality
Joe Tippens / Fenbendazole Protocol	Fenbendazole-centered supplement stack popularized through a remission story and online groups.	Anecdotal evidence only. Results reported online vary wildly. Needs large-scale human studies to prove safety and efficacy.
Ivermectin / Benzimidazole Protocol Claims	Aggressive online protocols combining ivermectin with fenbendazole or mebendazole.	Anecdotal evidence only. Results reported online vary wildly. Needs large-scale human studies to prove safety and efficacy.
Jane McLelland / Metabolic Blocking Claims	Multi-pathway metabolic strategy based around starving cancer fuel routes and blocking escape pathways.	Anecdotal evidence only. Results reported online vary wildly. Needs large-scale human studies to prove safety and efficacy.
Care Oncology-Style Repurposed Drug Claims	Clinic-associated repurposed-drug approach often discussed around four common medications.	Anecdotal evidence only. Results reported online vary wildly. Needs large-scale human studies to prove safety and efficacy.
Fasting-Mimicking Diet / Ketogenic / Press-Pulse Claims	Metabolic approaches focused on glucose, insulin, ketones, fasting stress, and treatment sensitivity.	Anecdotal evidence only. Results reported online vary wildly. Needs large-scale human studies to prove safety and efficacy.
Gerson, Gonzalez, Budwig, RSO, IPT, and Other Long-Running Claims	Older alternative or clinic-based approaches with strong testimonial communities and major evidence disputes.	Anecdotal evidence only. Results reported online vary wildly. Needs large-scale human studies to prove safety and efficacy.

Joe Tippens / Fenbendazole Protocol

Fenbendazole-centered supplement stack popularized through a remission story and online groups.

How people usually talk about it: Usually discussed as a broad, low-cost adjunctive stack for many cancers, especially by people looking at microtubules, inflammation, and anecdotal remission stories.

Claimed Components

Fenbendazole
Curcumin or high-bioavailability curcumin
Vitamin E, often tocopherol/tocotrienol forms
CBD oil in some versions
Common add-ons: berberine, quercetin, milk thistle, vitamin D, omega-3

Anecdotal Dose-Range Context

Dose ranges below are based on anecdotal reports, books, clinics, social posts, or publicly discussed protocol claims. They are not OncoForge recommendations. Large-scale studies are needed to verify safety and effectiveness. Consult your oncologist, pharmacist, or qualified clinician for safe dosing information.

Fenbendazole: public reports commonly mention 222-444 mg per dose, with schedules ranging from 3 days per week to daily use. Some 2025 discussions describe 444 mg daily.
Curcumin: public reports commonly mention about 500-1,000 mg/day; the older Tippens-style discussions often mention about 600 mg/day.
Vitamin E: public reports commonly mention 400-800 IU/day, though this can be risky with anticoagulants, surgery, bleeding risk, or some oncology drugs.
CBD oil: public reports commonly mention about 25 mg/day in the older Tippens-style stack, but products and THC content vary widely.
Common add-ons: berberine, quercetin, milk thistle, vitamin D, and omega-3 are often discussed, but dose claims vary by source.

Claimed Rationale

Fenbendazole is discussed for microtubule disruption and metabolic stress in preclinical models.
Curcumin is discussed for NF-kB, STAT3, COX-2, inflammatory signaling, and bioavailability problems.
Vitamin E and CBD are discussed as supportive or synergistic, though claims vary heavily.

Evidence Reality

Mostly anecdotal plus lab and animal research. There are many success claims online, but also many people who report no benefit. OncoForge does not claim this protocol treats cancer.

Major Cautions

Liver enzyme elevation has been reported with benzimidazoles.
Product quality and veterinary-vs-human formulations matter.
Vitamin E, CBD, curcumin, and other add-ons can interact with blood thinners, chemo, immunotherapy, anesthesia, and liver-metabolized drugs.

Research Watch

Newly reviewed studies on this protocol’s individual components, pulled from PubMed.

No linked studies yet. This panel fills in automatically as reviewed studies match this protocol’s components.

Ivermectin / Benzimidazole Protocol Claims

Aggressive online protocols combining ivermectin with fenbendazole or mebendazole.

How people usually talk about it: Usually discussed for aggressive, resistant, or metastatic cancers by people focused on WNT/beta-catenin, P-gp, mitochondrial stress, and drug repurposing.

Claimed Components

Ivermectin
Fenbendazole and/or mebendazole
Sometimes doxycycline, metformin, statins, berberine, curcumin, fasting, ketogenic diet, or DON-related claims
Supportive items such as liver support, binders, electrolytes, or anti-nausea strategies are often discussed

Anecdotal Dose-Range Context

Ivermectin: public tier claims commonly mention about 0.5 mg/kg three times weekly for lower-intensity versions, 1 mg/kg three times weekly for intermediate versions, 1-2 mg/kg daily for high-grade claims, and up to about 2.5 mg/kg daily in very aggressive online claims.
Mebendazole: public claims commonly mention escalation-style ranges such as 200 mg/day to 400 mg/day, with some aggressive versions discussing up to about 1,500 mg/day.
Fenbendazole: public high-intensity claims commonly mention about 1,000 mg three times weekly, though other sources use lower or daily ranges.
DON-related claims: some public discussions mention about 0.2-0.6 mg/kg IV/IM or up to about 1.1 mg/kg oral daily, but this is especially experimental and not a self-directed strategy.
IV vitamin C: public adjunct claims often mention about 1.5 g/kg two to three times weekly.
Vitamin D3: public loading claims sometimes mention 25,000-50,000 IU/day before dropping to lower maintenance ranges; this can be dangerous without labs.
Zinc: some public claims mention about 1 mg/kg/day during loading before much lower maintenance dosing.
Diet or fasting add-ons: some public claims discuss strict keto under 20 g carbs/day and 3-7 day fasts every 3-4 weeks, which can become dangerous in underweight or actively treated patients.

Claimed Rationale

Ivermectin is discussed for WNT/beta-catenin, PAK1, importin signaling, mitochondrial stress, and drug-efflux pathways in preclinical literature.
Benzimidazoles are discussed for microtubules, glucose uptake, and tumor metabolism.
The combined-protocol idea is usually to hit multiple cancer survival pathways at once.

Evidence Reality

The strongest claims are far ahead of the clinical evidence. Some mechanisms are interesting in lab settings, but the real-world protocol has not been validated as safe or effective for cancer.

Major Cautions

Ivermectin can cause neurologic toxicity, especially at high doses or with interacting drugs.
Benzimidazoles can stress liver function and blood counts.
Stacking many agents makes it hard to know what is helping, doing nothing, or causing harm.
Chemo, immunotherapy, anticoagulants, seizure meds, antifungals, macrolide antibiotics, and CYP/P-gp interactions need clinician review.

Research Watch

Newly reviewed studies on this protocol’s individual components, pulled from PubMed.

No linked studies yet. This panel fills in automatically as reviewed studies match this protocol’s components.

Jane McLelland / Metabolic Blocking Claims

Multi-pathway metabolic strategy based around starving cancer fuel routes and blocking escape pathways.

How people usually talk about it: Usually discussed by people interested in cancer metabolism, recurrence prevention, metastatic disease, or combining standard care with off-label metabolic blockers.

Claimed Components

Often discussed: metformin, statins, doxycycline, mebendazole, dipyridamole, aspirin, berberine, EGCG, curcumin, omega-3, low-glycemic diet
The actual stack varies by cancer type, metabolic theory, clinician involvement, and patient tolerance

Anecdotal Dose-Range Context

Metformin: public discussions often mention 500 mg once or twice daily, sometimes building toward 1,000 mg twice daily if tolerated and medically appropriate.
Berberine: public discussions often mention 500 mg two or three times daily with meals.
Statins: public discussions often mention conventional ranges such as atorvastatin 10-80 mg/day or equivalent statin dosing.
Doxycycline: public discussions often mention 100 mg once or twice daily, sometimes cycled rather than continuous.
Mebendazole: public discussions vary from 100-200 mg/day to higher multi-dose daily ranges depending on source.
Dipyridamole: public metabolic-blocking discussions sometimes mention 75 mg three or four times daily.
Aspirin: public discussions often mention low-dose aspirin ranges such as 81-100 mg/day, but bleeding risk matters.
Supplements such as EGCG, curcumin, omega-3, quercetin, or vitamin D vary widely and should not be copied without clinician oversight.

Claimed Rationale

The central idea is that cancer can switch fuels and pathways, so a single blocker may be bypassed.
Targets often discussed include glycolysis, glutamine use, fatty-acid oxidation, mTOR, AMPK, mevalonate pathway, inflammation, and angiogenesis.

Evidence Reality

Some individual components have real clinical uses and research signals. The full personalized combination approach remains unproven and highly context-dependent.

Major Cautions

Prescription drugs in this category can affect kidney function, liver function, blood sugar, bleeding risk, QT interval, gut health, and antibiotic resistance.
A metabolic strategy can be risky in cachexia, frailty, diabetes, kidney disease, or active treatment complications.

Research Watch

Newly reviewed studies on this protocol’s individual components, pulled from PubMed.

No linked studies yet. This panel fills in automatically as reviewed studies match this protocol’s components.

Care Oncology-Style Repurposed Drug Claims

Clinic-associated repurposed-drug approach often discussed around four common medications.

How people usually talk about it: Usually discussed as an adjunctive approach alongside standard oncology care, not as a stand-alone alternative.

Claimed Components

Metformin
Atorvastatin or another statin
Doxycycline
Mebendazole

Anecdotal Dose-Range Context

Metformin: public discussions commonly mention 500 mg twice daily, sometimes titrated upward if tolerated.
Atorvastatin: public discussions commonly mention 40 mg/day, though statin choice and dose vary.
Doxycycline: public discussions commonly mention 100 mg/day or 100 mg twice daily depending on the source.
Mebendazole: public discussions commonly mention 100 mg twice daily in lower-intensity versions, with some sources discussing higher doses.
Exact clinic protocols and patient adjustments vary; these ranges are not a substitute for a prescribing clinician.

Claimed Rationale

Metformin is discussed for AMPK/mTOR and insulin-related signaling.
Statins are discussed for the mevalonate pathway.
Doxycycline is discussed for mitochondrial and cancer-stem-cell related hypotheses.
Mebendazole is discussed for microtubules and metabolic stress.

Evidence Reality

More clinically grounded than many internet-only protocols because it uses known human drugs, but the combined anticancer claim is still not proven as a general treatment.

Major Cautions

Even familiar prescriptions can interact with oncology drugs.
Kidney, liver, muscle, GI, microbiome, and blood-sugar issues need monitoring.

Research Watch

Newly reviewed studies on this protocol’s individual components, pulled from PubMed.

No linked studies yet. This panel fills in automatically as reviewed studies match this protocol’s components.

Fasting-Mimicking Diet / Ketogenic / Press-Pulse Claims

Metabolic approaches focused on glucose, insulin, ketones, fasting stress, and treatment sensitivity.

How people usually talk about it: Usually discussed as a way to pressure cancer metabolism or improve treatment sensitivity, especially in people interested in the Warburg effect.

Claimed Components

Fasting-mimicking diet cycles
Ketogenic or very-low-carbohydrate diet
Calorie restriction in some versions
Hyperbaric oxygen, ketone supplements, exercise, or glucose-targeting agents in some press-pulse discussions

Anecdotal Dose-Range Context

Fasting-mimicking diet: public and research discussions often refer to 5-day low-calorie cycles, commonly repeated around treatment cycles or monthly in non-cancer contexts.
Ketogenic diet: public versions often discuss under 20-50 g net carbs/day, sometimes with ketone and glucose tracking.
Press-pulse concepts: public discussions often pair a ketogenic baseline with pulses such as fasting, hyperbaric oxygen, ketone supplements, 2-DG-related discussion, or other metabolic stressors.
Water fasting: online claims sometimes discuss 3-7 day fasts, but this can be dangerous in cancer patients without medical supervision.

Claimed Rationale

The core idea is to reduce glucose/insulin growth signaling while increasing metabolic stress on cancer cells.
Some research explores fasting or fasting-mimicking diets around chemotherapy, but patient selection matters.

Evidence Reality

There is active research, but this is not a universal cancer strategy. Results, tolerability, and safety vary heavily by patient and cancer context.

Major Cautions

Can be dangerous with weight loss, cachexia, diabetes, kidney disease, electrolyte issues, frailty, pregnancy, eating-disorder history, or active treatment side effects.
Should not be attempted around chemotherapy or surgery without oncology guidance.

Research Watch

Newly reviewed studies on this protocol’s individual components, pulled from PubMed.

No linked studies yet. This panel fills in automatically as reviewed studies match this protocol’s components.

Gerson, Gonzalez, Budwig, RSO, IPT, and Other Long-Running Claims

Older alternative or clinic-based approaches with strong testimonial communities and major evidence disputes.

How people usually talk about it: Usually discussed by people looking for non-standard, whole-body, detox, enzyme, cannabis, dietary, or lower-dose-chemo approaches.

Claimed Components

Gerson: juices, strict diet, supplements, coffee enemas
Gonzalez: pancreatic enzymes, diet types, supplements, detox practices
Budwig: flax oil and cottage cheese mixture plus diet/lifestyle claims
RSO: high-THC cannabis oil claims
IPT: insulin-potentiated low-dose chemotherapy in clinic settings

Anecdotal Dose-Range Context

Gerson claims: public descriptions often mention up to 13 juices/day, strict diet rules, potassium/iodine/liver-related supplements, and frequent coffee enemas.
Gonzalez claims: public descriptions often mention very high pancreatic enzyme burdens, sometimes well over 100 capsules/day, plus individualized diets and detox practices.
Budwig claims: public descriptions often mention flaxseed oil mixed with cottage cheese or quark, commonly in daily tablespoon-level amounts.
RSO claims: public descriptions often mention gradual THC oil escalation, sometimes toward 1 g/day, which is a very high exposure for many people.
IPT claims: insulin and chemotherapy dosing belongs in a medical clinic only; copying online dose details would be dangerous.

Claimed Rationale

These approaches use very different theories: detoxification, enzymes, fatty-acid membrane ideas, cannabinoid effects, or insulin-mediated drug delivery.
Public claims rely heavily on testimonials and clinic narratives.

Evidence Reality

Claims of success are not proof. Some have been studied and criticized; others remain mostly testimonial. OncoForge does not endorse them.

Major Cautions

Coffee enemas can cause electrolyte problems, infections, burns, or worse.
High THC can cause sedation, anxiety, falls, drug interactions, and impaired judgment.
IPT carries hypoglycemia and chemotherapy risks.
Alternative programs can delay needed standard care.

Research Watch

Newly reviewed studies on this protocol’s individual components, pulled from PubMed.

No linked studies yet. This panel fills in automatically as reviewed studies match this protocol’s components.